MiR-338-3p inhibits epithelial-mesenchymal transition in gastric cancer cells by targeting ZEB2 and MACC1/Met/Akt signaling
Na Huang(Nanopolis Suzhou (China)), Wangjun Liao(Sun Yat-sen University)
Cited by 110
Related Papers
Efficacy, Safety, and Correlative Biomarkers of Toripalimab in Previously Treated Recurrent or Metastatic Nasopharyngeal Carcinoma: A Phase II Clinical Trial (POLARIS-02)
|Journal of Clinical Oncology|2021|350
XB130 promotes proliferation and invasion of gastric cancer cells
|Journal of Translational Medicine|2014|133
MiR‐219‐5p inhibits hepatocellular carcinoma cell proliferation by targeting glypican‐3
|FEBS Letters|2012|102